Carregant...
A Phase I/II adaptive design for heterogeneous groups with application to a stereotactic body radiation therapy trial
Dose-finding studies that aim to evaluate the safety of single agents are becoming less common, and advances in clinical research have complicated the paradigm of dose finding in oncology. A class of more complex problems, such as targeted agents, combination therapies and stratification of patients...
Guardat en:
| Publicat a: | Pharm Stat |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608237/ https://ncbi.nlm.nih.gov/pubmed/25962576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1686 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|